• Biotalys officially opens new headquarters and research facilities in Ghent

    Thursday September 9th 2021

  • Flamingo Therapeutics expands alliance with Ionis Pharmaceuticals to develop RNA-targeted therapies for oncology

    Thursday September 9th 2021

  • Newton Biocapital invests in PRISM BioLab to support development of a unique peptide mimetic technology platform to discover new drugs for intractable diseases

    Thursday September 9th 2021

  • ViroVet and The Pirbright Institute are first to demonstrate efficacy of antivirals in ASFV infected pigs

    Thursday September 9th 2021

  • Ardena acquires Idifarma from Suanfarma, adding spray drying technology and high potency capabilities

    Monday September 6th 2021

  • Novalis Biotech Acceleration invests in San Francisco-based Modality.AI - technology that ‘self-drives’ neurological and psychiatric assessments

    Friday September 3rd 2021

  • Quality by Design zet nieuwe stap in groeiverhaal: Qarad vervoegt QbD Group

    Thursday September 2nd 2021

  • Biocartis launches Idylla™ SARS-CoV-2/Flu/RSV Panel

    Thursday September 2nd 2021

  • Your news here?

  • ExeVir announces first patient enrolled in phase 1b/2 clinical study evaluating XVR011 as antiviral treatment of patients hospitalised for COVID-19

    Wednesday September 1st 2021

  • Galapagos announces planned retirement of CEO

    Tuesday August 31st 2021

  • Sequana Medical appoints Jackie Fielding, former Medtronic VP, to its Board of Directors

    Tuesday August 31st 2021


Strategic Partners